GSAP
Gamma-secretase-activating protein
Also known as: GSAP_HUMAN, LOC54103, PION
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A4D1B5
- Gene
- GSAP
- Ensembl
- ENSG00000186088
- Chromosome
- 7
- Canonical length
- 854 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Accumulation of neurotoxic amyloid-beta is a major hallmark of Alzheimer disease (AD; MIM 104300). Formation of amyloid-beta is catalyzed by gamma-secretase (see PSEN1; MIM 104311), a protease with numerous substrates. PION, or GSAP, selectively increases amyloid-beta production through a mechanism involving its interaction with both gamma-secretase and its substrate, the amyloid-beta precursor protein (APP; MIM 104760) C-terminal fragment (APP-CTF) (He et al., 2010 [PubMed 20811458]).[supplied by OMIM, Nov 2010]
Canonical amino-acid sequenceUniProt
854 residues, UniProt reviewed canonical sequence.
>A4D1B5|GSAP
1 MALRLVADFD LGKDVLPWLR AQRAVSEASG AGSGGADVLE NDYESLHVLN VERNGNIIYT
61 YKDDKGNVVF GLYDCQTRQN ELLYTFEKDL QVFSCSVNSE RTLLAASLVQ STKEGKRNEL
121 QPGSKCLTLL VEIHPVNNVK VLKAVDSYIW VQFLYPHIES HPLPENHLLL ISEEKYIEQF
181 RIHVAQEDGN RVVIKNSGHL PRDRIAEDFV WAQWDMSEQR LYYIDLKKSR SILKCIQFYA
241 DESYNLMFEV PLDISLSNSG FKLVNFGCDY HQYRDKFSKH LTLCVFTNHT GSLCVCYSPK
301 CASWGQITYS VFYIHKGHSK TFTTSLENVG SHMTKGITFL NLDYYVAVYL PGHFFHLLNV
361 QHPDLICHNL FLTGNNEMID MLPHCPLQSL SGSLVLDCCS GKLYRALLSQ SSLLQLLQNT
421 CLDCEKMAAL HCALYCGQGA QFLEAQIIQW ISENVSACHS FDLIQEFIIA SSYWSVYSET
481 SNMDKLLPHS SVLTWNTEIP GITLVTEDIA LPLMKVLSFK GYWEKLNSNL EYVKYAKPHF
541 HYNNSVVRRE WHNLISEEKT GKRRSAAYVR NILDNAVKVI SNLEARNLGP RLTPLLQEED
601 SHQRLLMGLM VSELKDHFLR HLQGVEKKKI EQMVLDYISK LLDLICHIVE TNWRKHNLHS
661 WVLHFNSRGS AAEFAVFHIM TRILEATNSL FLPLPPGFHT LHTILGVQCL PLHNLLHCID
721 SGVLLLTETA VIRLMKDLDN TEKNEKLKFS IIVRLPPLIG QKICRLWDHP MSSNIISRNH
781 VTRLLQNYKK QPRNSMINKS SFSVEFLPLN YFIEILTDIE SSNQALYPFE GHDNVDAEFV
841 EEAALKHTAM LLGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GSAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- spleen: 18 nTPM
- lung: 17 nTPM
- liver: 15 nTPM
- tonsil: 12 nTPM
- lymph node: 12 nTPM
- parathyroid gland: 11 nTPM
Single-cell type
- nk-cells: 285 nCPM
- b-cells: 248 nCPM
- kupffer cells: 203 nCPM
- macrophages: 196 nCPM
- microglia: 194 nCPM
- neutrophils: 174 nCPM
Immune cell
- myeloid DC: 16 nTPM
- memory B-cell: 16 nTPM
- NK-cell: 15 nTPM
- naive B-cell: 14 nTPM
- classical monocyte: 13 nTPM
- intermediate monocyte: 12 nTPM
Brain region
- hypothalamus: 6.9 nTPM
- white matter: 6.5 nTPM
- choroid plexus: 5.9 nTPM
- thalamus: 5.8 nTPM
- medulla oblongata: 5.7 nTPM
- midbrain: 5.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Gamma-secretase-activating protein family
- Gamma-secretase-activating protein, C-terminal domain
- gamma-Secretase-activating protein C-term
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GSAP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GSAP as an antibody target. Whether an autoantibody or antibody against GSAP could matter depends on whether native GSAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GSAP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GSAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...